We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Lateral Flow Test Detects Bacteria Causing Gingivitis and Cardiovascular Diseases

By LabMedica International staff writers
Posted on 20 Oct 2023
Print article
Image: The new test can warn consumers about periodontal disease which can lead to heart diseases (Photo courtesy of University of Cincinnati)
Image: The new test can warn consumers about periodontal disease which can lead to heart diseases (Photo courtesy of University of Cincinnati)

Gingivitis, the initial stage of gum disease, is caused by bacteria that can make their way into the bloodstream and result in cardiovascular disease as well as other serious health conditions. A newly designed device now provides an early warning system for tooth decay that may result from conditions like gingivitis and periodontitis.

In order to develop the gingivitis test, engineers at the University of Cincinnati (Cincinnati, OH, USA) faced the challenge of creating a device capable of identifying the specific bacteria responsible for gingivitis. The researchers, who have been exploring biosensing for various applications, are focusing on saliva for point-of-care (POC) tests. Saliva is an ideal substance for testing since it's easy to collect and plentiful. However, saliva is also a complex mixture containing elements like proteins, peptides, DNA, and other compounds, each potentially signaling different health conditions, which makes isolating a particular biomarker for analysis difficult.

To resolve this issue, researchers pretreated the sample using potato starch to remove a protein called amylase that could interfere with the test results. Their point-of-care lateral flow assay (LFA) device uses antibodies that react to the endotoxins found in the bacteria. The team will undertake further development to improve assay sensitivity using saliva samples and explore its ability to detect multiple lipopolysaccharides (LPS) molecules related to diseases for more accurate diagnostics of patients' health. Finally, because the sensitivity of the current antibody-based detection is significantly affected by the performance of the conjugate antibody, the researchers will work on developing aptamer-based sandwich lateral flow assay for improved flexibility and performance.

“It’s been quite the challenge to get to the point where we can detect this toxin created by the bacteria responsible for gingivitis,” said Andrew Steckl, an Ohio Eminent Scholar and distinguished research professor in UC’s College of Engineering and Applied Science. “There are good reasons to use saliva. It’s relatively plentiful and easy to obtain through noninvasive methods. And saliva has a lot of important elements that can act as indicators of your health.”

Related Links:
University of Cincinnati 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Hemoglobin Testing System
VARIANTnbs

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Protein ‘signatures’ obtained via a blood sample can be used to predict the onset of 67 diseases (Photo courtesy of Queen Mary University of London)

Protein Signatures in Blood Can Predict Risk of Developing More Than 60 Diseases

Measuring specific proteins to diagnose conditions like heart attacks, where troponin is tested, is a well-established clinical practice. Now, new research highlights the broader potential of protein measurements... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Pathology

view channel
Image: The tool can improve precision oncology by accurately predicting molecular subtypes and therapy responses (Photo courtesy of Shutterstock)

Computational Tool Integrates Transcriptomic Data for Improved Breast Cancer Diagnosis and Treatment

Breast cancer is the most commonly diagnosed cancer globally, presenting in various subtypes that require precise identification for effective, personalized treatment. Traditionally, cancer subtyping has... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.